Cardiovascular Outcomes of Hypogonadal Men Receiving Testosterone Replacement Therapy: A Meta-analysis of Randomized Controlled Trials.

No statistically significant difference in all-cause mortality was observed between TRT and control groups in hypogonadal men.

• Analysis drawn from 26 randomized controlled trials with 10,941 total participants
• Sensitivity analysis supported the robustness of this finding
• Publication bias assessment also supported the finding's robustness
• Study exclusively focused on hypogonadal patients, distinguishing it from prior research

No statistically significant difference in cardiovascular-related mortality was found between the TRT group and the control group.

• Cardiovascular-related mortality was among the clinical outcomes assessed across 26 RCTs
• 10,941 participants were included in the meta-analysis
• Sensitivity analysis confirmed the robustness of this finding
• Meta-regression found no significant association between cardiovascular mortality and covariates including age, diabetes, hypertension, dyslipidemia, and smoking

TRT was not associated with statistically significant increases in myocardial infarction, stroke, congestive heart failure, atrial fibrillation, pulmonary embolism, or venous thrombosis.

• All eight clinical outcomes—all-cause mortality, cardiovascular-related mortality, myocardial infarction, stroke, congestive heart failure, atrial fibrillation, pulmonary embolism, and venous thrombosis—showed no significant differences
• The meta-analysis included 26 randomized controlled trials and 10,941 participants
• Sensitivity analysis and publication bias assessment supported these findings
• The exclusive focus on hypogonadal patients is noted as a distinguishing feature of the study

Meta-regression analysis found no significant associations between cardiovascular clinical outcomes and potential covariates including age, diabetes, hypertension, dyslipidemia, and smoking.

• Five covariates were examined: age, diabetes, hypertension, dyslipidemia, and smoking
• None of the covariates showed a significant association with the cardiovascular outcomes studied
• This finding suggests that baseline cardiometabolic risk factors did not modify the relationship between TRT and cardiovascular outcomes in this population

The study identified a need for further long-term research involving diverse populations to strengthen the evidence base regarding TRT and cardiovascular outcomes.

• Authors note that the current findings offer reassurance but are not considered definitive
• Further research is described as 'essential to strengthen the evidence base and broaden the applicability of these findings'
• Long-term studies and inclusion of diverse populations are specifically identified as research needs
• The study contrasted its findings with prior observational studies including those by Vigen et al, Finkle et al, Layton et al, and Wallis et al